.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Merck
Cantor Fitzgerald
Federal Trade Commission
Queensland Health
Accenture
Dow
McKinsey
Covington
Teva

Generated: July 26, 2017

DrugPatentWatch Database Preview

LANOXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Lanoxin, and when can generic versions of Lanoxin launch?

Lanoxin is a drug marketed by Concordia Pharms Inc and Covis Pharma Bv and is included in two NDAs.

The generic ingredient in LANOXIN is digoxin. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for Tradename: LANOXIN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list11
Bulk Api Vendors: see list69
Clinical Trials: see list7
Patent Applications: see list9,694
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LANOXIN at DailyMed

Pharmacology for Tradename: LANOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-001Sep 30, 1997RXYesNo► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
LANOXIN
digoxin
INJECTABLE;INJECTION009330-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-004Sep 30, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
LANOXIN PEDIATRIC
digoxin
INJECTABLE;INJECTION009330-004Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-002Sep 30, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Citi
Healthtrust
Teva
Mallinckrodt
Deloitte
US Department of Justice
Farmers Insurance
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot